Study S000272

Male Fertility Preservation: Efficacy Evaluation of GLP-1Receptor Agonist Therapy for Infertility in Obese Males - A Multicenter Clinical Randomized Controlled Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07179120
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: SINGLE
Status: NOT_YET_RECRUITING
Enrollment: 180
Start: 2026-05-01
Primary completion: 2026-08-12
Lead sponsor: First Affiliated Hospital of Wenzhou Medical University
Conditions: Obesity-related Male Infertility
Interventions: DRUG:Semaglutide (Rybelsus®); DRUG:Tirzepatide; BEHAVIORAL:Standardized Lifestyle Intervention
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change from Baseline in Sperm Concentration (million/mL) at Week 32 of Intervention [Baseline and Week 32]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.